LAKE OSWEGO, Ore.–(BUSINESS
WIRE)–BIOTRONIK, a worldwide leader in manufacturing cardiac
medical devices and pioneer of remote patient management solutions, today
announced it has successfully completed its final interoperability testing
process for BIOTRONIK Home Monitoring®, an Internet-based system for
patient and implantable cardiac device information.
During the week of January 9, 2012, BIOTRONIK participated in the “Integrating
the Healthcare Enterprise” (IHE) North American Connectathon in Chicago, Illinois,
to test its implantable device cardiac observation (IDCO) profile. This testing1
demonstrated the ability of BIOTRONIK Home Monitoring® to connect to
third-party electronic health record (EHR) systems and cardiovascular data
management systems using defined industry standards. The connecting technology
from the BIOTRONIK Home Monitoring® system to the EHRs is called BIOTRONIK EHR DataSync®.
The conclusion from this successful testing is that
BIOTRONIK EHR DataSync® will enable physicians and hospitals to share data
seamlessly, which should increase productivity, eliminate redundant medical
device management systems and improve clinical decision making and quality of
care. In this round of testing, BIOTRONIK proved the ability of BIOTRONIK
EHR DataSync® to connect with widely implemented EHR vendor systems (e.g.,
Epic and Medical Micrographics), as well as emerging and established
cardiovascular data management systems (e.g., ScottCares OneView™ CRM).
The IHE developed their testing process to promote the
adoption of standards that enable healthcare information to be shared
seamlessly across clinical settings. The IHEs goals are to drive standards for
interoperability, to increase efficiency, and to reduce costs to healthcare
customers, such as those in the cardiology, radiology and laboratory markets.
About BIOTRONIK EHR DataSync®
Implantable cardiac devices are also designed to capture and record information
about medical device performance and patient heart rhythms that is vital to
patient care. BIOTRONIK Home Monitoring® quickly organizes this information and
allows data to be sent directly and securely to a clinics or a hospitals EHR
system. That data is then available to include in the patients personal health
“Electronic health records support efficient access to
important patient healthcare information, so making this data readily available
via secure data transport is vital,” said Jake Langer, President of BIOTRONIK,
Inc. “Streamlined connectivity to critical device and lead data is an
increasingly important priority for physicians and the broader U.S. healthcare
network, and therefore BIOTRONIK made it a priority too. This demonstration of
our systems broad capabilities proves BIOTRONIKs willingness and ability to
provide yet another breakthrough, best-in-class innovation in accessing patient
Data integrity is guaranteed and has been proven through
validation testing. Data security is ensured by using U.S. Commerce Department
encryption methods. In addition, the BIOTRONIK Home Monitoring® system adheres
to patient privacy standards and requirements for the electronic transmission
of health information in accordance with the Health Insurance Portability and
Accountability Act of 1996 (HIPAA) standards.
About BIOTRONIK Home Monitoring®
BIOTRONIK Home Monitoring® is the first and only remote patient management
system with FDA approval to replace device interrogation during in-office
follow-up visits. BIOTRONIK Home Monitoring® allows for the safe reduction of
conventional clinic follow-up visits and early detection of patient clinical
events, based on results of the TRUST landmark trial.2–3
The system is unique because it allows continuous,
automatic, wireless remote monitoring of patient and device status with daily
updates-all independent from any patient interaction.
With immediate access to patient information through the
secure BIOTRONIK Home Monitoring® website, physicians can remotely monitor and
assess patient device data and determine the level of care needed. Alert
notifications can be customized to fit each clinics workflow, helping to
optimize clinic efficiency.
BIOTRONIK Home Monitoring® has pioneered advances in remote
patient management since its first U.S. clinical application in 2001.
Today, BIOTRONIK Home Monitoring® is extensively used with a growing number of
patients in more than 3,800 clinics and 55 countries worldwide.
About BIOTRONIK SE & Co. KG
As one of the worlds leading manufacturers of cardiovascular medical devices,
with several million devices implanted, BIOTRONIK is represented in over 100
countries by its global workforce of over 5,600 employees. Known for having its
finger on the pulse of the medical community, BIOTRONIK assesses the challenges
physicians face, and provides the best solutions for all phases of patient
care, ranging from diagnosis to treatment to patient management. Quality,
innovation and reliability define BIOTRONIK and its growing success, and
deliver confidence and peace of mind to physicians and their patients
More information: www.biotronik.com
1 Data on file.
2 Varma N et al., Circulation, 2010, 122, 325–332.
3 Varma N et al., Circ Arrhythm Electrophysiol, 2010, 3:428–436.
Posted by Sean Fenske, Editor-in-Chief, MDT